View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Repotrectinib 160, Non-Small Cell Lung Cancer, Cycle 2+
Protocol-ID: 555 V2.0 (Mini), REPO160, NSCLC, C2+Indication(s)
- Lung Carcinoma, Non-Small Cell; ICD-10 C34.-
ROS1+ - Tumor Biomarker Defined
NTRK Gene Fusion
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. |
Valid since: 04.12.2024